Correlation Between Pasithea Therapeutics and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and ABVC Biopharma, you can compare the effects of market volatilities on Pasithea Therapeutics and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and ABVC Biopharma.
Diversification Opportunities for Pasithea Therapeutics and ABVC Biopharma
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Pasithea and ABVC is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and ABVC Biopharma go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and ABVC Biopharma
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to generate 0.79 times more return on investment than ABVC Biopharma. However, Pasithea Therapeutics Corp is 1.27 times less risky than ABVC Biopharma. It trades about -0.03 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.03 per unit of risk. If you would invest 1,960 in Pasithea Therapeutics Corp on August 26, 2024 and sell it today you would lose (1,650) from holding Pasithea Therapeutics Corp or give up 84.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. ABVC Biopharma
Performance |
| Timeline |
| Pasithea Therapeutics |
| ABVC Biopharma |
Pasithea Therapeutics and ABVC Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and ABVC Biopharma
The main advantage of trading using opposite Pasithea Therapeutics and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |